Renasant Bank’s Medtronic MDT Stock Holding History

Renasant Bank’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272K	Buy	3,135 +664	+27%	+$63.6K	0.19%	115
2025 Q4	$237K	Hold	2,471	–	–	0.16%	127
2025 Q3	$235K	Sell	2,471 -16	-0.6%	-$1.47K	0.15%	131
2025 Q2	$217K	Sell	2,487 -898	-27%	-$76.2K	0.14%	141
2025 Q1	$304K	Buy	3,385 +236	+7%	+$21.1K	0.2%	118
2024 Q4	$252K	Sell	3,149 -521	-14%	-$45.1K	0.16%	140
2024 Q3	$330K	Sell	3,670 -579	-14%	-$48.7K	0.22%	122
2024 Q2	$334K	Buy	4,249 +1,467	+53%	+$120K	0.23%	110
2024 Q1	$242K	Sell	2,782 -657	-19%	-$56.1K	0.17%	149
2023 Q4	$283K	Sell	3,439 -764	-18%	-$58.2K	0.23%	126
2023 Q3	$329K	Buy	4,203 +466	+12%	+$39K	0.28%	110
2023 Q2	$329K	Buy	3,737 +42	+1%	+$3.62K	0.27%	118
2023 Q1	$298K	Buy	3,695 +287	+8%	+$23.4K	0.23%	139
2022 Q4	$265K	Buy	+3,408	New	+$276K	0.2%	158

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renasant Bank's MDT Position: Q1 2026 in Review

Renasant Bank increased its Medtronic (MDT) stake by 27% in Q1 2026, buying an estimated $63.6K and bringing the position to 3,135 shares worth $272K. The position accounts for 0.19% of the portfolio, ranked #115.

Renasant Bank first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $334K in Q2 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Renasant Bank held 3,135 shares of Medtronic worth $272K as of Q1 2026.
Renasant Bank bought 664 Medtronic shares in Q1 2026, an estimated $63.6K.
Medtronic made up 0.19% of Renasant Bank's portfolio in Q1 2026, its #115 holding.
Renasant Bank first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
Renasant Bank's Medtronic position peaked at $334K in Q2 2024.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Renasant Bank's 13F filing for Q1 2026, filed 29 Apr 2026.